Search results
Results From The WOW.Com Content Network
Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur , Mortimer , and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.
Purdue Pharma L.P., the U.S. Supreme Court overturned the settlement in a 5–4 decision. [76] On January 23, 2025, the Sackler family and Purdue settled the lawsuit they faced, in a $7.4bn deal with states and individuals. The Family agreed to pay $6.5bn over 15 years, while Purdue agreed on $900mn in settlements. [77]
Sackler joined Purdue Pharma in 1971, as assistant to his father, the company's president. [10] He became head of research and development and head of marketing. Sackler was a key figure in the development of Oxycontin, being the moving force behind Purdue Pharma's research around 1990 that pushed Oxycontin to replace MS Contin that was about to have generic competition.
At the time of Arthur Sackler's death in 1987, Purdue Pharma was a small drug company. [4] In 1996, Purdue introduced its opioid drug, OxyContin. [12] By 2001, eighty percent of Purdue Pharma's revenue came from the sale of OxyContin worth $3 billion. [4]
This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources. The timeline of the opioid epidemic includes selected events related to the origins of Stamford, Connecticut-based Purdue Pharma, the Sackler family, the development and marketing of oxycodone, selected FDA activities related to the abuse ...
The book examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family's central role in the opioid epidemic. [1] [2] [3] The book followed Keefe's 2017 article on the Sackler family in The New Yorker, titled "The Family That Built an Empire of Pain". [4] [5]
Massachusetts v. Purdue is a lawsuit filed on August 14, 2018, suing the Stamford, Connecticut-based company Purdue Pharma LP, which created and manufactures OxyContin, "one of the most widely used and prescribed opioid drugs on the market", and Purdue's owners, the Sacklers [1] accusing them of "widespread fraud and deception in the marketing of opioids, and contributing to the opioid crisis ...
He acquired Purdue Pharma together with his brothers Arthur M. Sackler and Mortimer Sackler. Purdue Pharma is the developer of OxyContin, the drug at the center of the opioid epidemic in the United States. [2] [3] [4] Sackler and his family have been linked to the rise of direct pharmaceutical marketing and the opioid crisis. [3]